毕马威（KPMG）：2026年全球技术报告：生命科学行业洞察（英文版）（16页）.pdf

1、KPMG.Make the Difference.KPMG International|KPMG Global tech report 2026:Life SciencesValue realization AuthorsRecommendationsMethodologyKey findingsTechnology investment Technology adoption and maturity ForewordForewordThis report provides a snapshot on technology adoption,investment,and value real

2、ization within the Life Sciences sector.The research is based on a global survey of 124 Life Sciences tech function leaders in large and mid-sized pharmaceutical,biotechnology and medical device companies;as well as product distributors,and contract research organizations.The findings suggest the se

3、ctor has progressed beyond experimentation into broad adoption of core technologies.Investment remains measured,with organizations prioritizing stability and compliance over rapid expansion.Overall,the sector remains in the early phases of maturity and value realization,with most benefits concentrat

4、ed primarily towards operational efficiency rather than transformational growth.The results also highlight a gap between technology ambitions and the actions required to deliver them.Our data shows that,although the industry has demonstrated the effectiveness of digital technology and is enabling re

5、turns on investment,challenges remain in securing funding,establishing governance,and achieving large-scale implementation.To optimize operations and support a more collaborative,innovative,and patient-focused future,Life Sciences companies should make more decisive technology moves that rebalance r

6、isk away from adoption and compliance,towards scale,speed,and value capture.We hope the perspectives shared in this report support informed decision-making in a rapidly evolving landscape.Liz Claydon Global Head of Life Sciences and Global Head of Deal Advisory KPMG InternationalKPMG Global tech rep